人類乳突病毒檢測市場規模、佔有率、趨勢、產業分析報告：依產品、應用、技術、最終用途、地區，2025-2034年市場預測

根據Polaris Market Research的最新研究，全球人類乳突病毒（HPV）檢測市場規模預計到2034年將達到55.4792億美元。本研究報告深入分析了當前的市場動態，並分析了未來的市場成長。

人類乳突病毒（HPV）檢測市場涵蓋用於檢測生物樣本中HPV病毒的診斷檢測產品的銷售和分銷。這些檢測主要用於女性健康，在子宮頸癌篩檢中發揮關鍵作用，因為持續感染某些高風險HPV基因型是導致子宮頸癌的主要原因。該市場涵蓋各種檢測方式，例如識別HPV DNA或RNA的分子檢測、相關設備、耗材以及實驗室和醫療保健提供者提供的檢測服務。

隨著人們日益意識到HPV與子宮頸癌之間的關聯、國家子宮頸癌篩檢計畫的實施以及診斷技術的進步，人類乳突病毒檢測市場經歷了顯著成長。主要的市場驅動力是HPV檢測日益被採用作為主要篩檢工具或與傳統HPV和子宮頸抹片檢查結合使用。此外，更靈敏、更特異的HPV檢測方法的開發以及自我採集選項的推出，提高市場滲透率和可及性。在持續的研究、市場對早期癌症檢測日益成長的需求以及政府積極推動預防性醫療保健的推動下，市場前景仍然光明。

人類乳突病毒檢測市場報告重點

依應用劃分，子宮頸癌篩檢細分市場目前佔據全球最大市場佔有率。這是因為其在常規篩檢計畫中發揮重要作用，並且越來越重視癌前病變的早期發現。

依產品劃分，耗材子細分市場佔據最大市場佔有率，因為試劑、檢測試劑盒和其他一次性材料是HPV檢測的重複使用材料，而HPV檢測在世界各地被大量用於篩檢和診斷。

依技術劃分，PCR子細分市場佔據最大市場佔有率，因為基於PCR的檢測方法在檢測HPV DNA方面具有高靈敏度和特異性，使其成為全球子宮頸癌篩檢的首選技術。

依最終用途劃分，醫院和診所佔據最大市場佔有率，因為這些醫療機構是大部分定期接受子宮頸癌篩檢和診斷的人群的主要護理點。

依地區劃分，北美目前在人類乳突病毒檢測市場中佔據最大市場佔有率。預計在預測期內，亞太地區的人類乳突病毒檢測市場成長率最高。

活躍於人類乳突病毒檢測市場的主要公司包括QIAGEN N.V.、F. Hoffmann-La Roche AG、Hologic, Inc.、Abbott Laboratories、Becton, Dickinson and Company（BD）、Thermo Fisher Scientific Inc.、Danaher Corporation（Cepheid）、bioMerieux S.A.、GenMark Diagnostics, Inc.（Roche收購）、Agilent Technologies, Inc.、Luminex Corporation（DiaSorin S.p.A.）。

目錄

第1章 簡介

第2章 執行摘要

第3章 研究方法

第4章 全球人類乳突病毒檢測市場洞察

• 市場概況
• 人類乳突病毒檢測市場動態
  • 驅動因素與機會
    • 提高認知度與篩檢項目
    • 檢測方法的技術進步
    • 不斷上升的HPV感染率
  • 限制因素與挑戰
    • 認知度和偵測率低
• PESTEL分析
• 人類人類乳突病毒檢測市場趨勢
• 價值鏈分析
• COVID-19 影響分析

第5章 全球人類乳突病毒檢測市場（依應用）

• 主要調查結果
• 簡介
• 子宮頸癌篩檢
• 陰道癌篩檢

第6章 全球人類乳突病毒檢測市場（依產品）

• 主要調查結果
• 簡介
• 設備
• 耗材
• 服務

第7章 全球人類乳突病毒檢測市場（依技術）

• 主要調查結果
• 簡介
• PCR
• 免疫診斷
• 其他技術

第8章 全球人類乳突病毒檢測市場（依最終用途）

• 主要調查結果
• 簡介
• 醫院和診所
• 實驗室
• 其他

第9章 全球人類乳突病毒檢測市場（依地區）

• 主要調查結果
• 簡介
  • 2020-2034年人類乳突病毒檢測市場評估（依地區）
• 北美
  • 北美：依應用，2020-2034
  • 北美：依產品，2020-2034
  • 北美：依技術，2020-2034
  • 北美：依最終用途，2020-2034
  • 美國
  • 加拿大
• 歐洲
  • 歐洲：依應用，2020-2034
  • 歐洲：依產品，2020-2034
  • 歐洲：依技術，2020-2034
  • 歐洲：依最終用途，2020-2034
  • 英國
  • 法國
  • 德國
  • 義大利
  • 西班牙
  • 荷蘭
  • 俄羅斯
  • 歐洲其他地區
• 亞太地區
  • 亞太地區：依應用，2020-2034
  • 亞太地區：依產品，2020-2034
  • 亞太地區：依技術，2020-2034
  • 亞太地區：依最終用途，2020-2034
  • 中國
  • 印度
  • 馬來西亞
  • 日本
  • 印尼
  • 韓國
  • 澳洲
  • 其他亞太地區
• 中東和非洲
  • 中東和非洲：依應用，2020-2034
  • 中東和非洲：依產品，2020-2034
  • 中東和非洲：依技術，2020-2034
  • 中東和非洲：依最終用途，2020-2034
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列
  • 南非
  • 中東和非洲其他地區
• 拉丁美洲
  • 拉丁美洲：依應用，2020-2034
  • 拉丁美洲：依產品，2020-2034
  • 拉丁美洲：依技術，2020-2034
  • 拉丁美洲：依最終用途，2020-2034
  • 墨西哥
  • 巴西
  • 阿根廷
  • 拉丁美洲其他地區

第10章 競爭格局

• 擴張與收購分析
  • 擴張
  • 收購
• 夥伴關係/合作/協議/公開

第11章 公司簡介

• Abbott Laboratories
• Agilent Technologies, Inc.
• Becton, Dickinson and Company（BD）
• bioMerieux S.A.
• Danaher Corporation（Cepheid）
• F. Hoffmann-La Roche AG
• GenMark Diagnostics, Inc.（acquired by Roche）
• Hologic, Inc.
• Luminex Corporation（DiaSorin S.p.A.）
• QIAGEN N.V.
• Thermo Fisher Scientific Inc.

The global human papillomavirus (HPV) testing market size is expected to reach USD 5,547.92 Million by 2034, according to a new study by Polaris Market Research. The report "Human Papillomavirus Testing Market Size, Share, Trends, Industry Analysis Report: By Product (Instruments, Consumables, Services), By Application, By Technology, By End-use, and Region- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The human papillomavirus (HPV) testing market encompasses the sale and distribution of diagnostic tests used to detect the presence of the HPV virus in biological samples. Primarily utilized in women's health, these tests play a critical role in screening for cervical cancer, as persistent infections with certain high-risk HPV genotypes are the primary cause of this disease. The market includes various testing methodologies, such as molecular tests that identify HPV DNA or RNA, as well as related instruments, consumables, and testing services offered by laboratories and healthcare providers.

The human papillomavirus testing market is experiencing significant growth, driven by increasing awareness of the link between HPV and cervical cancer, the implementation of national cervical cancer screening programs, and advancements in diagnostic technologies. A key market drive is the growing adoption of HPV testing as a primary screening tool or in conjunction with traditional HPV and Pap test. Furthermore, the development of more sensitive and specific HPV assays, along with the introduction of self-sampling options, is enhancing market penetration and accessibility. The market outlook remains positive, fueled by ongoing research, increasing market demand for early cancer detection, and supportive government initiatives promoting preventive healthcare.

Human Papillomavirus Testing Market Report Highlights:

By application, the cervical cancer screening subsegment currently holds the largest market share globally due to its established role in routine screening programs and the strong emphasis on early detection of precancerous lesions.

By product, the consumables subsegment accounts for the largest market share because of the recurring need for reagents, assay kits, and other disposable materials in the high volume of HPV testing procedures conducted worldwide for screening and diagnosis.

By technology, the PCR subsegment commands the largest market share owing to the high sensitivity and specificity of PCR-based assays in detecting HPV DNA, making it the preferred technology for cervical cancer screening on a global scale.

By end-use, the hospitals & clinics subsegment holds the largest market share as these healthcare settings serve as the primary points of care for a significant portion of the population undergoing routine cervical cancer screening and diagnostic processes.

By region, North America currently holds the largest market share in the human papillomavirus testing market. The Asia Pacific region is anticipated to exhibit the highest growth rate in the human papillomavirus testing market over the forecast period.

Some of the major players actively operating in the human papillomavirus testing market include QIAGEN N.V., F. Hoffmann-La Roche AG, Hologic, Inc., Abbott Laboratories, Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., Danaher Corporation (Cepheid), bioMerieux S.A., GenMark Diagnostics, Inc. (acquired by Roche), Agilent Technologies, Inc., and Luminex Corporation (DiaSorin S.p.A.).

Polaris Market Research has segmented the Human Papillomavirus Testing market report based on application, product, technology, end-use, and region:

By Application Outlook (Revenue - USD Million, 2020-2034)

Cervical Cancer Screening

Vaginal Cancer Screening

By Product Outlook (Revenue - USD Million, 2020-2034)

Instruments

Consumables

Services

By Technology Outlook (Revenue - USD Million, 2020-2034)

PCR

Immunodiagnostics

Other Technologies

By End-Use Outlook (Revenue - USD Million, 2020-2034)

Hospitals & Clinics

Laboratories

Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

US

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Human Papillomavirus Testing Market Insights

• 4.1. Human Papillomavirus Testing Market - Market Snapshot
• 4.2. Human Papillomavirus Testing Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising Awareness and Screening Programs
    • 4.2.1.2. Technological Advancements in Testing Methods
    • 4.2.1.3. Increasing Prevalence of HPV Infections
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Low awareness and screening rates
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Human Papillomavirus Testing Market Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Human Papillomavirus Testing Market, by Application

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• 5.3. Cervical Cancer Screening
  • 5.3.1. Global Human Papillomavirus Testing Market, by Cervical Cancer Screening, by Region, 2020-2034 (USD Million)
• 5.4. Vaginal Cancer Screening
  • 5.4.1. Global Human Papillomavirus Testing Market, by Vaginal Cancer Screening, by Region, 2020-2034 (USD Million)

6. Global Human Papillomavirus Testing Market, by Product

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• 6.3. Instruments
  • 6.3.1. Global Human Papillomavirus Testing Market, by Instruments, by Region, 2020-2034 (USD Million)
• 6.4. Consumables
  • 6.4.1. Global Human Papillomavirus Testing Market, by Consumables, by Region, 2020-2034 (USD Million)
• 6.5. Services
  • 6.5.1. Global Human Papillomavirus Testing Market, by Services, by Region, 2020-2034 (USD Million)

7. Global Human Papillomavirus Testing Market, by Technology

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• 7.3. PCR
  • 7.3.1. Global Human Papillomavirus Testing Market, by PCR, by Region, 2020-2034 (USD Million)
• 7.4. Immunodiagnostics
  • 7.4.1. Global Human Papillomavirus Testing Market, by Immunodiagnostics, by Region, 2020-2034 (USD Million)
• 7.5. Other Technologies
  • 7.5.1. Global Human Papillomavirus Testing Market, by Other Technologies, by Region, 2020-2034 (USD Million)

8. Global Human Papillomavirus Testing Market, by End-Use

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• 8.3. Hospitals & Clinics
  • 8.3.1. Global Human Papillomavirus Testing Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Million)
• 8.4. Laboratories
  • 8.4.1. Global Human Papillomavirus Testing Market, by Laboratories, by Region, 2020-2034 (USD Million)
• 8.5. Others
  • 8.5.1. Global Human Papillomavirus Testing Market, by Others, by Region, 2020-2034 (USD Million)

9. Global Human Papillomavirus Testing Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Human Papillomavirus Testing Market Assessment, By Geography, 2020-2034 (USD Million)
• 9.3. Human Papillomavirus Testing Market - North America
  • 9.3.1. North America: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
  • 9.3.2. North America: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
  • 9.3.3. North America: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
  • 9.3.4. North America: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.3.5. Human Papillomavirus Testing Market - US
    • 9.3.5.1. US: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.3.5.2. US: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.3.5.3. US: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.3.5.4. US: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.3.6. Human Papillomavirus Testing Market - Canada
    • 9.3.6.1. Canada: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.3.6.2. Canada: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.3.6.3. Canada: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.3.6.4. Canada: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• 9.4. Human Papillomavirus Testing Market - Europe
  • 9.4.1. Europe: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
  • 9.4.2. Europe: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
  • 9.4.3. Europe: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
  • 9.4.4. Europe: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.5. Human Papillomavirus Testing Market - UK
    • 9.4.5.1. UK: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.5.2. UK: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.5.3. UK: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.5.4. UK: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.6. Human Papillomavirus Testing Market - France
    • 9.4.6.1. France: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.6.2. France: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.6.3. France: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.6.4. France: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.7. Human Papillomavirus Testing Market - Germany
    • 9.4.7.1. Germany: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.7.2. Germany: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.7.3. Germany: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.7.4. Germany: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.8. Human Papillomavirus Testing Market - Italy
    • 9.4.8.1. Italy: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.8.2. Italy: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.8.3. Italy: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.8.4. Italy: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.9. Human Papillomavirus Testing Market - Spain
    • 9.4.9.1. Spain: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.9.2. Spain: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.9.3. Spain: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.9.4. Spain: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.10. Human Papillomavirus Testing Market - Netherlands
    • 9.4.10.1. Netherlands: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.10.2. Netherlands: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.10.3. Netherlands: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.10.4. Netherlands: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.11. Human Papillomavirus Testing Market - Russia
    • 9.4.11.1. Russia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.11.2. Russia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.11.3. Russia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.11.4. Russia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.12. Human Papillomavirus Testing Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.12.2. Rest of Europe: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.12.3. Rest of Europe: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.12.4. Rest of Europe: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• 9.5. Human Papillomavirus Testing Market - Asia Pacific
  • 9.5.1. Asia Pacific: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
  • 9.5.2. Asia Pacific: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
  • 9.5.3. Asia Pacific: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
  • 9.5.4. Asia Pacific: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.5. Human Papillomavirus Testing Market - China
    • 9.5.5.1. China: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.5.2. China: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.5.3. China: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.5.4. China: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.6. Human Papillomavirus Testing Market - India
    • 9.5.6.1. India: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.6.2. India: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.6.3. India: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.6.4. India: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.7. Human Papillomavirus Testing Market - Malaysia
    • 9.5.7.1. Malaysia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.7.2. Malaysia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.7.3. Malaysia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.7.4. Malaysia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.8. Human Papillomavirus Testing Market - Japan
    • 9.5.8.1. Japan: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.8.2. Japan: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.8.3. Japan: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.8.4. Japan: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.9. Human Papillomavirus Testing Market - Indonesia
    • 9.5.9.1. Indonesia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.9.2. Indonesia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.9.3. Indonesia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.9.4. Indonesia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.10. Human Papillomavirus Testing Market - South Korea
    • 9.5.10.1. South Korea: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.10.2. South Korea: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.10.3. South Korea: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.10.4. South Korea: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.11. Human Papillomavirus Testing Market - Australia
    • 9.5.11.1. Australia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.11.2. Australia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.11.3. Australia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.11.4. Australia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.12. Human Papillomavirus Testing Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.12.2. Rest of Asia Pacific: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.12.3. Rest of Asia Pacific: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.12.4. Rest of Asia Pacific: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• 9.6. Human Papillomavirus Testing Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
  • 9.6.2. Middle East & Africa: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
  • 9.6.3. Middle East & Africa: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
  • 9.6.4. Middle East & Africa: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.6.5. Human Papillomavirus Testing Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.6.5.2. Saudi Arabia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.6.5.3. Saudi Arabia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.5.4. Saudi Arabia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.6.6. Human Papillomavirus Testing Market - UAE
    • 9.6.6.1. UAE: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.6.6.2. UAE: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.6.6.3. UAE: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.6.4. UAE: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.6.7. Human Papillomavirus Testing Market - Israel
    • 9.6.7.1. Israel: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.6.7.2. Israel: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.6.7.3. Israel: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.7.4. Israel: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.6.8. Human Papillomavirus Testing Market - South Africa
    • 9.6.8.1. South Africa: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.6.8.2. South Africa: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.6.8.3. South Africa: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.8.4. South Africa: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.6.9. Human Papillomavirus Testing Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.6.9.2. Rest of Middle East & Africa: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.6.9.3. Rest of Middle East & Africa: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.9.4. Rest of Middle East & Africa: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• 9.7. Human Papillomavirus Testing Market - Latin America
  • 9.7.1. Latin America: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
  • 9.7.2. Latin America: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
  • 9.7.3. Latin America: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
  • 9.7.4. Latin America: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.7.5. Human Papillomavirus Testing Market - Mexico
    • 9.7.5.1. Mexico: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.7.5.2. Mexico: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.7.5.3. Mexico: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.7.5.4. Mexico: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.7.6. Human Papillomavirus Testing Market - Brazil
    • 9.7.6.1. Brazil: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.7.6.2. Brazil: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.7.6.3. Brazil: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.7.6.4. Brazil: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.7.7. Human Papillomavirus Testing Market - Argentina
    • 9.7.7.1. Argentina: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.7.7.2. Argentina: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.7.7.3. Argentina: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.7.7.4. Argentina: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.7.8. Human Papillomavirus Testing Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.7.8.2. Rest of Latin America: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.7.8.3. Rest of Latin America: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.7.8.4. Rest of Latin America: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Abbott Laboratories
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Agilent Technologies, Inc.
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Becton, Dickinson and Company (BD)
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. bioMerieux S.A.
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Danaher Corporation (Cepheid)
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. F. Hoffmann-La Roche AG
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. GenMark Diagnostics, Inc. (acquired by Roche)
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Hologic, Inc.
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Luminex Corporation (DiaSorin S.p.A.)
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. QIAGEN N.V.
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. Thermo Fisher Scientific Inc.
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development

List of Tables:

• Table 1 Global Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 2 Global Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 3 Global Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 4 Global Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 5 North America: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 6 North America: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 7 North America: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 8 North America: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 9 U.S.: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 10 U.S.: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 11 U.S.: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 12 U.S.: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 13 Canada: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 14 Canada: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 15 Canada: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 16 Canada: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 17 Europe: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 18 Europe: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 19 Europe: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 20 Europe: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 21 UK: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 22 UK: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 23 UK: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 24 UK: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 25 France: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 26 France: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 27 France: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 28 France: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 29 Germany: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 30 Germany: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 31 Germany: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 32 Germany: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 33 Italy: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 34 Italy: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 35 Italy: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 36 Italy: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 37 Spain: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 38 Spain: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 39 Spain: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 40 Spain: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 41 Netherlands: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 42 Netherlands: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 43 Netherlands: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 44 Netherlands: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 45 Russia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 46 Russia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 47 Russia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 48 Russia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 49 Rest of Europe: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 50 Rest of Europe: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 51 Rest of Europe: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 52 Rest of Europe: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 53 Asia Pacific: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 54 Asia Pacific: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 55 Asia Pacific: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 56 Asia Pacific: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 57 China: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 58 China: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 59 China: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 60 China: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 61 India: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 62 India: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 63 India: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 64 India: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 65 Malaysia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 66 Malaysia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 67 Malaysia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 68 Malaysia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 69 Japan: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 70 Japan: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 71 Japan: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 72 Japan: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 73 Indonesia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 74 Indonesia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 75 Indonesia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 76 Indonesia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 77 South Korea: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 78 South Korea: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 79 South Korea: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 80 South Korea: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 81 Australia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 82 Australia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 83 Australia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 84 Australia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 85 Rest of Asia Pacific: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 86 Rest of Asia Pacific: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 87 Rest of Asia Pacific: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 88 Rest of Asia Pacific: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 89 Middle East & Africa: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 90 Middle East & Africa: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 91 Middle East & Africa: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 92 Middle East & Africa: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 93 Saudi Arabia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 94 Saudi Arabia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 95 Saudi Arabia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 96 Saudi Arabia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 97 UAE: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 98 UAE: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 99 UAE: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 100 UAE: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 101 Israel: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 102 Israel: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 103 Israel: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 104 Israel: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 105 South Africa: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 106 South Africa: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 107 South Africa: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 108 South Africa: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 109 Rest of Middle East & Africa: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 110 Rest of Middle East & Africa: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 111 Rest of Middle East & Africa: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 112 Rest of Middle East & Africa: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 113 Latin America: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 114 Latin America: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 115 Latin America: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 116 Latin America: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 117 Mexico: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 118 Mexico: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 119 Mexico: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 120 Mexico: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 121 Brazil: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 122 Brazil: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 123 Brazil: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 124 Brazil: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 125 Argentina: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 126 Argentina: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 127 Argentina: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 128 Argentina: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 129 Rest of Latin America: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 130 Rest of Latin America: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 131 Rest of Latin America: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 132 Rest of Latin America: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)

List of Figures:

• Figure 1. Global Human Papillomavirus Testing Market, 2020-2034 (USD Million)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Application
• Figure 7. Global Human Papillomavirus Testing Market, by Application, 2024 & 2034 (USD Million)
• Figure 8. Market by Product
• Figure 9. Global Human Papillomavirus Testing Market, by Product, 2024 & 2034 (USD Million)
• Figure 10. Market by Technology
• Figure 11. Global Human Papillomavirus Testing Market, by Technology, 2024 & 2034 (USD Million)
• Figure 12. Market by End-Use
• Figure 13. Global Human Papillomavirus Testing Market, by End-Use, 2024 & 2034 (USD Million)